Despite its utility for the dichotomous differentiation of pathological and nonpathological gamblers, some have questioned the use of the South Oaks Gambling Screen (SOGS) for discriminating individuals across the entire range of gambling problems. Using methods from item response theory, we derived a six-item version of the SOGS. This shortened version of the SOGS performed uniformly across a sample of pathological gamblers and a sample of students and resulted in five levels of discrimination and the following interpretation: a score of 1 reveals potential for problems; 2 reveals likely problem gambling; 3 or 4 items endorsed represent significant levels of problems noticeable by others; while 5 or 6 represents severe problems with significant financial involvement. We discuss the implications and remaining limitations of using this shortened measure for the continuum-based assessment of gambling problems.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0306-4603(02)00262-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fungal Planet description sheets: 1697-1780.
Fungal Syst Evol
December 2024
Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands.
Novel species of fungi described in this study include those from various countries as follows: , from accumulated snow sediment sample. , on leaf spots of . , on submerged decaying wood in sea water, on , as endophyte from healthy leaves of .
View Article and Find Full Text PDFChemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles.
Nat Nanotechnol
January 2025
Global Regulatory Affairs CMC, Sanofi, Marcy-l'Etoile, France.
Lipid nanoparticles (LNPs) for nucleic acid delivery often use novel lipids as functional excipients to modulate the biodistribution, pharmacokinetics, pharmacodynamics and efficacy of the nucleic acid. Novel excipients used in pharmaceutical products are subject to heightened regulatory scrutiny and often require data packages comparable to an active pharmaceutical ingredient. Although these regulatory requirements may help to ensure patient safety they also create economic and procedural barriers that can disincentivize innovation and delay clinical investigation.
View Article and Find Full Text PDFResponse to Letter to the Editor titled, "Does Evolocumab treatment reduce carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia?" by Christian Saleh.
Eur J Prev Cardiol
January 2025
Clinical Development, Amgen Inc., Thousand Oaks, CA, USA.
Mental Health Care Utilization and Prescription Rates Among Children, Adolescents, and Young Adults in France.
JAMA Netw Open
January 2025
CEReSS, Research Centre on Health Services and Quality of Life, Aix Marseille University, Marseille, France.
Importance: Amid escalating mental health challenges among young individuals, intensified by the COVID-19 pandemic, analyzing postpandemic trends is critical.
Objective: To examine mental health care utilization and prescription rates for children, adolescents, and young adults before and after the COVID-19 pandemic.
Design, Setting, And Participants: This population-based time trend study used an interrupted time series analysis to examine mental health care and prescription patterns among the French population 25 years and younger.
Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodies.
Ann Hematol
January 2025
Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Although survival rates for patients with newly diagnosed multiple myeloma (NDMM) have improved over recent decades, multiple myeloma (MM) remains without a cure for most. There is increasing consensus that achievement of deep remissions, especially minimal residual disease negativity (MRD -), in frontline treatment is crucial and translates into improved survival. The standard of care (SOC) for NDMM consists at minimum of a triplet regimen of therapies, with or without an autologous stem cell transplant, or a doublet regimen for certain ineligible, particularly frail patients who may have specific limitations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!